Performance. Defined.

InVitria Blog | Cell Culture and Biotech Manufacturing Insights

WEBINAR: The Cell Culture Revolution: Commercializing Therapeutic Cell Systems

join the cell culture revolution webinar!

We are pleased to announce that on Tuesday, September 18th InVitria will be hosting a webinar in partnership with Genetic Engineering & Biotechnology News!

Here is the webinar abstract:

The advent of recombinant antibody production in mammalian cell lines has revolutionized modern medicine. Clinical success of these agents has challenged the underlying biological manufacturing systems to produce quantities sufficient to supply the ever-expanding commercial markets. 

A fundamental focus for commercialization efforts was optimization of cell culture media components utilized in the biologic manufacturing process. With primary and stem cell applications poised to make similar strides in clinical progress as monoclonal antibodies did in the 1990s, manufacturing methodologies must progress in parallel to ensure the clinical success of these novel cell-based therapeutics. In this GEN webinar, we will discuss the current state of the cell culture media space for primary and stem cell expansion. Moreover, we will discuss the reagents and development strategies needed to remove serum-derived proteins from media formulations to produce chemically defined and blood component free, or blood-free, expansion processes for therapeutic cell types.

A live Q&A session will follow the webinar, don't forget to sign up today!

Join the cell culture revolution webinar

Randy Alfano

Written by Randy Alfano

Dr. Alfano joined InVitria in 2012 and currently leads the product development team, where he utilizes his expertise in media design and optimization for biomanufacturing and stem/primary cells. Prior to joining the company, Dr. Alfano was the Process Development Manager for XBiotech in Austin, TX where he specialized in the development and optimization of the company’s cell culture processes in mammalian cells for cancer biologics. Previously, he was promoted from Postdoctoral Fellow to Senior Scientist at the Cancer Research Institute of Scott and White Hospital where he developed in vivo animal models for metastatic prostate cancer and was instrumental in developing thorough in vitro and in vivo models for immunostimulatory antigens. Dr. Alfano received his Ph.D. from Texas A&M Health Science Center College of Medicine.

Subscribe to our Blog:

Follow InVitria: